Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer

Martina Kluth1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Heinke Volta1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Mohammad Hussein1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Billurvan Taskin1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Sohall Frogh1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Christina Möller-Koop1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Franziska Büscheck1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Frank Jacobsen1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Maria Christina Tsourlakis1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Andreas M Lübke1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Andrea Hinsch1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Till Clauditz1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Markus Graefen2 Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Hans Heinzer2 Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Hartwig Huland2 Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Sarah Minner1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Guido Sauter1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Waldemar Wilczak1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]

Thorsten Schlomm2 Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;3 Department of Urology, Section for Prostate Cancer Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;4 Department of Urology, Charitè Universitätsmedizin Berlin, Berlin, Germany

Ronald Simon1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, [email protected]Correspondence[email protected]

show all

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer

Articles from other publishers (4)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer

Citations (4)

Articles from other publishers (4)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date